Lectures 30/31 Flashcards

Cholinomimetics - Feng

1
Q

Cholinomimetics

A
  • Transmission of impulses throughout cholinergic NS is mediated by ACh
  • Compounds that produce ACh’s pharmacological effects by mimicking for ACh = cholinergics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cholinergics Therapeutics

A
  1. Relief of post-operative muscular weakness of gut and urinary bladder
  2. Reduction of IOP in some glaucomas
  3. Relief of muscular weakness in myasthenia gravis
  4. Relief of symptoms of Alzheimer disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACh

A
  • Organic cation that acts on neurotransmitters in PNS and CNS
  • Ester of acetate and choline
  • *Recognize structure**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neurochemistry of ACh

A
  • Serine decarboxylase takes serine and converts it to choline
  • Choline is recycled by ChAT into ACh
  • 2 sources of choline: synthesis from serine and recycling from ACh hydrolysis (50%)
  • ACh can be used intracellularly and extracellularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cholinergic Receptors

A
  • Not all chol. receptors are identical
  • Two types: nicotinic and muscarinic
  • Named after natural product showing receptor selectivity
  • L-+-Muscarine - activates chol. receptors on smooth and cardiac muscle recognize structure
  • Nicotine activates chol. receptors in nervous system and skeletal muscle Know structure
  • Neither agonist is native in body, artificial
  • Both types can be activated by ACh - NON-SELECTIVE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Muscarine

A
  • Cyclic analog of ACh - carbonyl and Beta-C linked
  • Less flexible due to 5-membered ring in molecular skeleton
  • 3 chiral centers, but only muscarine is naturally occuring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Muscarine Receptor Models

A
  • G-coupled protein receptor
  • 5 different subtypes of receptors (M1-M5)
  • 7 hydrophobic, transmembrane, helical domains
  • 3 hydrophilic extracellular and intracellular loops each
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nicotinic Receptors

A
  • Ligand gated channels
  • Ion channels where ACh is the gate keeper
  • Modulates sodium and potassium ion concentrations
  • Multiple types of these receptors too
  • Two ACh bind to alpha subunits and their neighbors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACh Stereochemistry

A
  • Doesn’t exhibit configurational isomers (no chiral centers)
  • Many agonist/antagonists are optical isomers (naturally occuring)
  • Therefore the stereochemistry is important for ACh
  • ACh receptors have chirality with antagonist/agonist effects connected to their stereochemistry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3-D Dimension

A

-This disposition of ACh is defined by torsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Torsion Angle

A

Angle between two planes (plane containing A-B & B-C and plane containing C-D & B-C)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Structural (constitutional) Isomers

A

Compounds of the same molecular formula with different connectivity (structure, constitution)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Conformational Isomers

A

Compounds of the same structure that differ in rotation around one or more single bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Configurational Isomers

A

Compounds of the same structure that differ in one or more aspects of stereochemistry (how groups are oriented in space - enantiomers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Conformations of ACh

A
  • Several freely rotatable single bonds
  • Large number of conformations
  • Active conformation is not necessarily the most stable
  • Many studies suggest that the main conformaiton is synclinal conformaiton
  • Expected to be antiperiplanar, but intramolecular interactions expected to be the cause of difference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Active Conformation

A
  • Rigid analogues of ACh
  • Rotatable bonds are “locked” in place with rings
  • Restricts the number of possible conformations
  • Defines separation of ester and nitrogen pharmacores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ester and Nitrogen Distances for Receptors

A

Muscarinic - 4.4 A

Nicotinic - 5.9 A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anticlinal Form

A
  • Conformation ACh is likely interacting with receptor in
  • Rigidly conformed in ACTM
  • Cis and trans isomers are synperiplanar and anticlinal respectively
  • Trans = potent, cis = no activity
  • Cis is more thermodynamically favorable though and may be favored in solution
  • *Adopts different state in different environments for stability or interaction purposes**
19
Q

ACh Pharmacologic Properties

A
  • Easily synthesized
  • Use: induces miosis in certain ocular surgeries
  • Formulations: IO and IV
  • ACh is highly susceptible in first pass metabolism
  • Quaternary amine makes it not easily absorbed through membranes (too polar)
  • Duration of action - 10-20 minutes, metabolized quickly by esterases
20
Q

Instability of ACh

A
  • Neighboring group activity (N+ — O(partial negative))
  • Increases the electrophilicity of carbonyl
  • Increases sensitivity to nucleophiles
  • Faster hydrolysis of esters (AChE)
21
Q

Categories of Cholinomimetic Drugs

A
  • Interacting with cholinergic receptors

- Increasing availability of ACh at sites

22
Q

Cholinoceptor Agonist

A
  • Directly acting
  • Activates Cholinoceptors
  • Choline esters (ACh, bethanechol) or alkaloids (pilocarpine)
23
Q

Anticholinoesterases

A
  • Indirectly act by inhibiting hydrolysis of ACh
  • Carbamates (physostigmine, neostigmine, edrophonium)
  • Phosphates (isoflurophate, antidote pralidoximine)
24
Q

Choline Esters

A
  • Requirement for chol. agonists
  • Stability to stomach acids and esterases
  • Selectivity for chol. receptors
  • Selectivity between mus. and nic. receptors
25
Q

Structural Variations of ACh

A
  • 4 possible sites to variate ACh since ACh is a poor therapeutic agent on its own
    1. Modification of quatenary ammonium
    2. Modification of ethylene bridge
    3. Modification of acyloxy group (R-CO)
    4. Substitution of ester group by other groups
26
Q

Modification of Quaternary Ammonium Options

A
  1. Replacement of nitrogen by other atoms

2. Replacing N-Me by H, N, O, or an alkyl

27
Q

Replacing Nitrogen

A
  • Only compounds with positive charge on atom in position of nitrogen had appreciable mus. activity
  • ALL nitrogen atom substituted compounds have less activity than ACh
  • Conclusions: positive charge is important for reactivity and don’t change the quaternary ammonium
28
Q

Replacing N-Me

A
  • Replacement of one N-Me by ethyl permits retention of chol, activity, more ethyl replacements decrease activity
  • Replacement with larger compounds loses almost all activity
  • Replacement with hydrogens leads to successive activity loss with each addition
  • Conclusions: N,N,N-trimethyl quaternary ammonium of ACh is optimum for potency, therefore nothing better than N-(Me)3 group, need at LEAST 2 Me on N
29
Q

Modifications of Ethylene Bridge

A
  • Five-atom rule: need to have 5 atoms between quart. N and terminal H to maximize mus. activity
  • Less atoms has similar effects but less potency than ACh
  • More atoms causes activity to rapidly be lost
  • Therefore distance is important for receptor binding and activity
30
Q

Modifying Ethylene Bridge - Adding Methyl

A
  • Acetyl - B - Methylcholine (methacholine) has similar muscarinic potency to ACh, used clinically
  • Methyl in the alpha position is more potent for nicotinic than muscarinic activity, but less potent than ACh in both
  • Difference arises from the methyl in the beta position acting as a steric shield to protect ester from nucleophiles and enzymes
  • Shield size and positioning is important, methyl is preferred, needs to be large enough to hinder esterase hydrolysis and small enough to hit in receptor binding site
31
Q

Methacholine

A
  • Placement of Methyl inhibits esterase binding and acts as a shield for nucleophilic attack
  • 3x more stable than ACh
  • Increasing the shield size increases its stability but decreases its activity
  • Selective for mus. over nic. receptors
  • S-enantiomer is more active than R, S matches muscarinic receptors (not selective for spec. subtypes)
32
Q

Modification of Acloxy (R-(C=O)O)

A
  • Carbamic acid esters (carbamate ester) of choline is more potent than acetates
  • Major advantages since it increases the stability and decreases AChE hydrolysis
  • Stabilizes carbonyl group of carbamate by delocalizing N’s lone pair onto carbonyl
33
Q

Carbamate Esters Properties

A
  • Resistant to hydrolysis, long acting
  • NH2 and CH3 are similar in size, fit in hydrophobic pocket, similar chemical and therefore biological properties
  • Muscarinic activity is equal to nicotinic activity
  • Used topically for glaucoma
34
Q

Carbamate Ester Steric + Electronic Properties

A
  • Not hydrolyzed reading by ChE, long duration
  • Orally active tablets
  • S-isomer is selective for muscarinic activity, almost 1000x more potent than R-enantiomer, similar to methacholine
  • Stimulates GI tract and urinary bladder after surgery
  • EX: Bethanechol
35
Q

Other Acetyl Group Replacements

A
  • Replacing with a larger or smaller group will be less potent than ACh
  • Extension of 5 atom rule
  • Can’t extend the molecule, only replace with NH2
36
Q

Substitution of Ester

A
  • Not essential for chol. activity
  • Many alkyl ethers of choline and thiocholine have chol. activity but are less potent
  • Not as capable of hydrogen bonding
  • Conclusions: Ester is still important for chol. activity
37
Q

SAR- Muscarinic Agonist

A
  • Based on quart. ammonium, ethylene bridge, and ester/acyloxy group
  • Methyl at B-carbon has increases mus. potency than nic.
38
Q

Muscarinic Agonist Physicochemical and PK Properties

A
  • Quart. and non-quart. ammonium salts are water soluble
  • Quart. chlorides and poorly orally soluble
  • Ester, lactone, and carbamates are relatively stable in aqueous media but prone to hydrolysis
39
Q

SARs for ACh Agonist

A
  1. Molecule must have positively charged N
  2. Size of alkyl groups subbed on N should not be larger than a methyl
  3. Should be oxygen atom, preferably ester-like oxygen capable of hydrogen bonding
  4. Should be 2-C unit between N & O
40
Q

Conclusions of ACh Modifications

A
  • Tight fit between ACh and binding
  • Methyl groups fit into small hydrophobic pockets
  • Esters interacting by hydrogen bonding
  • Quart. N interact by ionic binding
41
Q

Alkaloids

A
  • Cholinergic but not similar to ACh
  • Naturally occurring and contains N
  • Don’t conform with definition of synthetic sompounds not found in plants, closely related to natural alkaloids
42
Q

Pilocarpine

A
  • Example of an alkaloid
  • Extracted from leaves
  • Used for glaucoma as miotics
  • Mus. agonists to constrict pupil and increase aqueous flow
43
Q

Nicotine

A
  • Example of alkaloid
  • Bicyclic molecule
  • Basic with pKa of 8.5
  • Tight binding account for by similarities between ACh and nicotine
44
Q

Do all cholinomimetic drugs contain choline esters?

A

No. Many naturally and synthetic cholinomimetic drugs don’t have choline esters.